Pneumocystis jirovecii colonization in patients treated with infliximab

European Journal of Clinical Investigation

Volumn 41, Issue 3, 2011, Pages 343-348

  Wissmann, Gustavo ^a,b,c   Morilla, Rubén ^b,c   Martín Garrido, Isabel ^b   Friaza, Vicente ^b,c   Respaldiza, Nieves ^b,c   Povedano, Juan ^b   Praena Fernández, Juan M ^c   Montes Cano, Marco A ^b,c   Medrano, Francisco J ^b,c   Goldani, Luciano Z ^a   De La Horra, Carmen ^b,c   Varela, José M ^b,c   Calderón, Enrique J ^b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c CSIC   (Spain)

Author keywords

Colonization; Immunosuppression; Infliximab; Pneumocystis jirovecii; Pneumonia; Rheumatic diseases

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; PROTEIN SUBUNIT; RIBOSOME RNA;

ANKYLOSING SPONDYLITIS; ARTICLE; FUNGAL COLONIZATION; HUMAN; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MORBIDITY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LOGISTIC MODELS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; SPONDYLARTHROPATHIES; YOUNG ADULT;

EID: 79551675659     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02415.x     Document Type: Article

References (16)

1. Calderon-Sandubete EJ, Varela-Aguilar JM, Medrano-Ortega FJ, Nieto-Guerrero V, Respaldiza-Salas N, de la Horra-Padilla C et al. Historical perspective on Pneumocystis carinii infection. Protist 2002;153:303-10.
2. Kalden JR. Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases. Arthritis Res 2002;4:34S-40S.
3. Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007;52:1481-4.
4. Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H et al. Post-marketing surveillance of the safety profile of infliximab in 5, 000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:189-94.
5. Harigai M, Koike R, Miyasaka N. Pneumocystis pneumonia associated with Infliximab in Japan. N Engl J Med 2007;357: 1874-6.
6. Respaldiza N, Montes-Cano MA, Friaza V, Muñoz-Lobato F, Medrano FJ, Varela JM et al. Usefulness of Oropharyngeal Washings for identifying Pneumocystis jirovecii carriers. J Eukaryot Microbiol 2006;53:S100-1.
7. Mori S, Cho I, Ichiyasu H, Sugimoto M. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol 2008;18:240-6.
8. Montes-Cano MA, de la Horra C, Martin-Juan J, Varela JM, Torronteras R, Respaldiza N et al. Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis 2004;39:123-8.
9. Chen W, Havell EA, Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992;60:1279-84.
10. Poppers DM, Scherl EJ. Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care. Inflamm Bowel Dis 2008;14:106-13.
11. Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford) 2004;43:479-85.
12. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008;197:10-7.
13. Calderon EJ. Epidemiology of Pneumocystis infection in human. J Mycol Med 2009;19:270-5.
14. Dei-Cas E, Brun-Pascaud M, Bille-Hansen V, Allaert A, Aliouat EM. Animal models of pneumocystosis. FEMS Immunol Med Microbiol 1998;22:163-8.
15. Leigh TR, Wakefield AE, Peters SE, Hopkin JM, Collins JV. Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation 1992;54:468-70.
16. Wissmann G, Varela JM, Calderón E. Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization. Inflamm Bowel Dis 2008;14:1751-2.